• About CPF
    Company Profiles Awards Global Collaboration Media Center Subsidiary
  • Products & Services
    API and intermediates Dosage Services
  • R&D
  • News
    Company News Industry News
  • Contact Us
  • 中
About CPF Products & Services R&D News Contact Us
  • API and intermediates
  • Dosage
  • Services
  • A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
No.

Dosage

Strength

Indication

1 Relugolix Anhydrous Non-solvent Form 17-19kg
2 Remdesivir
3 Resmetirom Form I and Form λ 40-50 kg
4 Rimegepant Sulfate Form H1.5-1 8-12 kg
5 Rivaroxaban Form Ⅰ 140-150kg
6 Rosuvastatin Calcium Amorphous 205kg-225kg
7 Rosuvastatin Calcium Tablets 5mg/10mg/20mg/40mg Hypercholesterolemia
8 Ruxolitinib Phosphate As Innovator 14-17kg
1
About CPF
Products & Services
R&D
News
Contact us
Adress:NO. 518 Laodong East Road, Changzhou, Jiangsu, China
Phone:+86 519 88821493
E-Mail:zhangyajuan@czpharma.com
E-Mail:shm@czpharma.com

苏ICP备14053581号-3